{
  "abstract": "Cancer and acute ischaemic stroke are two leading causes of mortality worldwide. The association between these two diseases is being increasingly recognised, and with improvements in cancer mortality, the co-prevalence is increasing. Evidence suggested that cancer-related ischaemic stroke is a unique subtype of stroke, including a newly proposed schematic to define this subgroup of patients. Cancer-related ischaemic stroke encompasses a heterogeneous group of mechanisms that requires individualised diagnostic evaluation and multidisciplinary collaboration. In this narrative review, we describe the pathophysiology, workup, and management considerations in patients with cancer and ischaemic stroke.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Neurology, Tufts Medicine, Boston, MA, 02111, United States",
    "Department of Neurology, Duke University School of Medicine, Durham, NC, 27710, United States"
  ],
  "article_type": "review article",
  "arxiv": null,
  "author_total": 4,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Shivam Patel"
    },
    {
      "affs": [
        0
      ],
      "name": "Soma Sengupta"
    },
    {
      "affs": [
        1
      ],
      "name": "Wuwei Feng"
    },
    {
      "affs": [
        1
      ],
      "name": "Dylan Ryan"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7afrpad3kz662.bib",
  "cited_by": 0,
  "doi": "10.1016/j.clinme.2026.100656",
  "fulltext_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730225/?tool=EBI",
  "id": "7afrpad3kz662",
  "issns": [
    "1470-2118",
    "1473-4893"
  ],
  "landing_url": "https://europepmc.org/article/PMC/PMC13730225",
  "language": "eng",
  "licence": "CC-BY-NC-ND",
  "licence_label": "CC BY-NC-ND",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "CME: Neuro-oncology"
    ],
    [
      "openalex",
      "2728|Acute Ischemic Stroke Management"
    ]
  ],
  "openalex": "W7222009582",
  "pdf_url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13730225/pdf/?tool=EBI",
  "pmcid": "PMC13730225",
  "pmid": "42880717",
  "published": "2026-09-01",
  "publisher": "Royal College of Physicians",
  "ris": "https://research.draconitic.com/paper/7afrpad3kz662.ris",
  "sources": [
    {
      "first_seen": "2026-11-04T15:20:47Z",
      "native_id": "PMC:PMC13730225",
      "source": "europepmc",
      "url": "https://europepmc.org/article/PMC/PMC13730225"
    },
    {
      "first_seen": "2026-11-07T12:22:49Z",
      "native_id": "PMC13730225",
      "source": "pmc",
      "url": "https://doi.org/10.1016/j.clinme.2026.100656"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2728|Acute Ischemic Stroke Management",
      "subfield": "neurology"
    }
  ],
  "title": "Pathophysiology, workup and treatment of cancer-related ischaemic stroke",
  "title_text": "Pathophysiology, workup and treatment of cancer-related ischaemic stroke",
  "type": "peer-reviewed",
  "updated_at": "2026-11-07T12:22:49Z",
  "url": "https://research.draconitic.com/paper/7afrpad3kz662",
  "venue": "Clinical medicine (London, England)",
  "versions": []
}